Nickel particles are present in Crohn's disease tissue and exacerbate intestinal inflammation in IBD susceptible mice.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
12 02 2022
Historique:
received: 22 12 2021
accepted: 28 12 2021
pubmed: 16 1 2022
medline: 11 2 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

Crohn's disease is an inflammatory disease of the gut caused by a complex interplay among genetic, microbial, and environmental factors. The intestinal tract is constantly exposed to metals and other trace elements ingested as food. Synchrotron radiation-induced X-ray fluorescence spectroscopy and X-ray absorption fine structure analysis revealed the deposition of nickel particles within Crohn's disease tissue specimens. After nickel particle stimulation, THP-1 cells showed filopodia formation and autophagic vacuoles containing lipid bodies. Nickel particles precipitated colitis in mice bearing mutations of the IBD susceptibility protein A20/TNFAIP3. Nickel particles also exacerbated dextran sulfate sodium-induced colitis in mice harboring myeloid cell-specific Atg5 deficiency. These findings illustrate that nickel particle ingestion may worsen Crohn's disease by perturbing autophagic processes in the intestine, providing new insights into environmental factors in Crohn's disease pathogenesis.

Identifiants

pubmed: 35032835
pii: S0006-291X(21)01762-9
doi: 10.1016/j.bbrc.2021.12.111
pii:
doi:

Substances chimiques

Autophagy-Related Protein 5 0
Nickel 7OV03QG267
Dextran Sulfate 9042-14-2
Tumor Necrosis Factor alpha-Induced Protein 3 EC 3.4.19.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-80

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hiroki Matsuda (H)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Yoichi Nibe-Shirakihara (Y)

Department of Pathological Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Japan.

Akiko Tamura (A)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Emi Aonuma (E)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Satoko Arakawa (S)

Department of Pathological Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Japan.

Kana Otsubo (K)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Yasuhiro Nemoto (Y)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Takashi Nagaishi (T)

Department of Advanced Therapeutics for G.I. Diseases, Tokyo Medical and Dental University, Tokyo, Japan.

Kiichiro Tsuchiya (K)

Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Shigeomi Shimizu (S)

Department of Pathological Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Japan.

Averil Ma (A)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Mamoru Watanabe (M)

Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.

Motohiro Uo (M)

Department of Advanced Biomaterials, Tokyo Medical and Dental University, Tokyo, Japan.

Ryuichi Okamoto (R)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Shigeru Oshima (S)

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: soshima.gast@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH